title: Is cyclosporine indicated in HLA-identical renal transplant recipients?
authors.affiliation: Transplantation Division, State University of New York Health Science Center, Brooklyn 11203.
authors.forename: N
authors.initials: N
authors.lastname: Sumrani
authors.forename: V
authors.initials: V
authors.lastname: Delaney
authors.forename: Z
authors.initials: Z
authors.lastname: Ding
authors.forename: R
authors.initials: R
authors.lastname: Davis
authors.forename: K
authors.initials: K
authors.lastname: Butt
authors.forename: J
authors.initials: J
authors.lastname: Hong
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005190:Family; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology*; D006648:Histocompatibility; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000379:methods*; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors
chemical_list: D003524:Cyclosporins; D006680:HLA Antigens; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone